Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Individual Susceptibility To Ephedrine Alkaloid AEs Cited By FDA Consultants

This article was originally published in The Tan Sheet

Executive Summary

Additional research would help determine whether certain individuals have enhanced sensitivity to the effects of ephedrine alkaloids, consultants retained by FDA to review adverse event reports involving the dietary supplement ingredient suggest.

You may also be interested in...



Ephedra Cardiovascular Side Effects "Minimal" - Columbia/Harvard Study

Ephedra/caffeine combination weight-loss supplements caused "minimal" cardiovascular side effects in a Columbia University/Harvard University clinical trial, researchers reported at the North American Association for the Study of Obesity annual scientific meeting in Long Beach, Calif.

Ephedra Cardiovascular Side Effects "Minimal" - Columbia/Harvard Study

Ephedra/caffeine combination weight-loss supplements caused "minimal" cardiovascular side effects in a Columbia University/Harvard University clinical trial, researchers reported at the North American Association for the Study of Obesity annual scientific meeting in Long Beach, Calif.

Ephedra Cardiovascular Side Effects "Minimal" - Columbia/Harvard Study

Ephedra/caffeine combination weight-loss supplements caused "minimal" cardiovascular side effects in a Columbia University/Harvard University clinical trial, researchers reported at the North American Association for the Study of Obesity annual scientific meeting in Long Beach, Calif.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS091098

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel